Nve Corp /New/ (NVEC) Stock Analysis and Metrics

Sector: Technology Industry: Semiconductors CIK: 0000724910

Market Cap 317.90 Mn

P/E 22.43

P/S 10.03

Div. Yield 0.06

ROIC (Qtr) 0.21

Revenue Growth (1y) (Qtr) 334.98

Add ratio to table...

About

Investment thesis

Bull case

NVEC’s recent earnings demonstrate a strategic pivot toward high‑margin, high‑value markets, most notably medical devices and autonomous systems. The company secured a two‑year extension with Abbott that includes price escalations, signaling strong recurring revenue streams from a long‑standing, large customer. Coupled with the 335 % surge in contract R&D income, this partnership suggests a growing pipeline of advanced sensor applications that can be monetized at premium prices. If the new wafer‑level chip‑scale manufacturing cluster comes online as scheduled, NVEC will be able to internalize packaging, reduce third‑party costs, and further protect margins while expanding throughput for these specialized devices.
NVEC’s focus on rare‑earth‑free ferrite magnet‑based sensors positions the firm to capitalize on supply‑chain anxieties in the semiconductor and medical device industries. The company has already begun selling sensors that use abundant iron‑oxygen ferrites, offering a compelling alternative to magnets that rely on scarce rare earth elements. As global regulators tighten export controls and as geopolitical tensions threaten supply continuity, demand for ferrite‑based solutions is likely to accelerate, creating a new niche market for NVEC’s sensors. The firm’s existing IP and manufacturing capability in spintronics further reinforce its competitive moat in this emerging segment.
The expansion of NVEC’s production footprint – a multimillion‑dollar investment already largely completed – signals confidence that demand will continue to rise in the coming years. While the first nine months of fiscal 2026 saw only a 0.4 % revenue increase, the company’s operating margin of 60 % and net margin of 54 % reflect efficient cost management and robust profitability. The anticipated 16–17 % effective tax rate for the full year indicates that NVEC will benefit from investment tax credits, thereby preserving cash flow and enabling further reinvestment in product development. With its advanced spintronics platform, NVEC is well‑positioned to feed the growing AI‑of‑things wave, which will require dense, low‑power sensors embedded in industrial automation, robotics, and automotive electronics.
Finally, NVEC’s management signals a long‑term vision that extends beyond incremental defense contracts. The Vice President of Advanced Technology highlighted progress in developing “world’s best electronics for high‑value markets such as medical devices, electric and autonomous vehicles, advanced factory and humanoid robotics.” By aligning its R&D pipeline with these strategic verticals, NVEC taps into markets that are expected to grow rapidly, while its small part size and high sensitivity give it a competitive edge in applications that demand miniaturization and precision. This alignment, coupled with a solid cash position and the ability to scale production, should translate into sustainable revenue growth in the mid‑term.

NVEC’s recent earnings demonstrate a strategic pivot toward high‑margin, high‑value markets, most notably medical devices and autonomous systems. The company secured a two‑year extension with Abbott that includes price escalations, signaling strong recurring revenue streams from a long‑standing, large customer. Coupled with the 335 % surge in contract R&D income, this partnership suggests a growing pipeline of advanced sensor applications that can be monetized at premium prices. If the new wafer‑level chip‑scale manufacturing cluster comes online as scheduled, NVEC will be able to internalize packaging, reduce third‑party costs, and further protect margins while expanding throughput for these specialized devices.
NVEC’s focus on rare‑earth‑free ferrite magnet‑based sensors positions the firm to capitalize on supply‑chain anxieties in the semiconductor and medical device industries. The company has already begun selling sensors that use abundant iron‑oxygen ferrites, offering a compelling alternative to magnets that rely on scarce rare earth elements. As global regulators tighten export controls and as geopolitical tensions threaten supply continuity, demand for ferrite‑based solutions is likely to accelerate, creating a new niche market for NVEC’s sensors. The firm’s existing IP and manufacturing capability in spintronics further reinforce its competitive moat in this emerging segment.
The expansion of NVEC’s production footprint – a multimillion‑dollar investment already largely completed – signals confidence that demand will continue to rise in the coming years. While the first nine months of fiscal 2026 saw only a 0.4 % revenue increase, the company’s operating margin of 60 % and net margin of 54 % reflect efficient cost management and robust profitability. The anticipated 16–17 % effective tax rate for the full year indicates that NVEC will benefit from investment tax credits, thereby preserving cash flow and enabling further reinvestment in product development. With its advanced spintronics platform, NVEC is well‑positioned to feed the growing AI‑of‑things wave, which will require dense, low‑power sensors embedded in industrial automation, robotics, and automotive electronics.
Finally, NVEC’s management signals a long‑term vision that extends beyond incremental defense contracts. The Vice President of Advanced Technology highlighted progress in developing “world’s best electronics for high‑value markets such as medical devices, electric and autonomous vehicles, advanced factory and humanoid robotics.” By aligning its R&D pipeline with these strategic verticals, NVEC taps into markets that are expected to grow rapidly, while its small part size and high sensitivity give it a competitive edge in applications that demand miniaturization and precision. This alignment, coupled with a solid cash position and the ability to scale production, should translate into sustainable revenue growth in the mid‑term.

Bear case

Despite headline growth, NVEC’s gross margin decline from 84 % to 79 % underscores a shift toward less profitable product lines and a heavier reliance on distributor sales, which inherently deliver lower margins. The management team acknowledged that the decrease was “due to a less profitable product mix and increased distributor sales,” yet provided no concrete plan to reverse this trend. If the company continues to sell more through distributors or cannot shift back to direct, it risks compressing profitability and eroding the high operating margin that has been a key driver of investor appeal.
The company’s recent reduction in R&D expense – a 9 % cut that followed the completion of wafer‑level packaging – raises concerns about future innovation depth. While the narrative suggests a reallocation of resources toward manufacturing, there is no assurance that the new equipment will deliver the promised throughput or cost savings. Any delays or performance shortfalls in the new cluster could stall product development, jeopardizing the rollout of the miniaturized sensors that the company claims will unlock new markets. In a rapidly evolving spintronics landscape, a pause in R&D could leave NVEC vulnerable to competitors with more robust pipelines.
The company’s revenue growth over the full fiscal year was essentially flat (0.4 % increase), indicating that the 23 % quarterly surge was a temporary rebound rather than a sustained trend. Management admitted that the first two quarters saw declines, with contract R&D revenue falling 8 % year‑over‑year. Without a clear, repeatable driver, investors may view the revenue performance as cyclical and highly sensitive to customer demand fluctuations, especially given the defense market’s inherent volatility and the regulatory bottlenecks in medical device approvals.
NVEC’s strategic focus on emerging sectors – autonomous vehicles, robotics, AI‑of‑things – is attractive but fraught with execution risk. The company lacks concrete evidence of sales or regulatory approvals in these high‑growth arenas. The Q&A revealed that while they are monitoring MagNav technology, they do not have a product ready for that market, implying a gap between ambition and capability. Moreover, the capital expenditures of $2.18 million for new equipment represent a significant cash outlay; if the return on this investment does not materialize swiftly, it could pressure cash flow and limit future financing flexibility.

Despite headline growth, NVEC’s gross margin decline from 84 % to 79 % underscores a shift toward less profitable product lines and a heavier reliance on distributor sales, which inherently deliver lower margins. The management team acknowledged that the decrease was “due to a less profitable product mix and increased distributor sales,” yet provided no concrete plan to reverse this trend. If the company continues to sell more through distributors or cannot shift back to direct, it risks compressing profitability and eroding the high operating margin that has been a key driver of investor appeal.
The company’s recent reduction in R&D expense – a 9 % cut that followed the completion of wafer‑level packaging – raises concerns about future innovation depth. While the narrative suggests a reallocation of resources toward manufacturing, there is no assurance that the new equipment will deliver the promised throughput or cost savings. Any delays or performance shortfalls in the new cluster could stall product development, jeopardizing the rollout of the miniaturized sensors that the company claims will unlock new markets. In a rapidly evolving spintronics landscape, a pause in R&D could leave NVEC vulnerable to competitors with more robust pipelines.
The company’s revenue growth over the full fiscal year was essentially flat (0.4 % increase), indicating that the 23 % quarterly surge was a temporary rebound rather than a sustained trend. Management admitted that the first two quarters saw declines, with contract R&D revenue falling 8 % year‑over‑year. Without a clear, repeatable driver, investors may view the revenue performance as cyclical and highly sensitive to customer demand fluctuations, especially given the defense market’s inherent volatility and the regulatory bottlenecks in medical device approvals.
NVEC’s strategic focus on emerging sectors – autonomous vehicles, robotics, AI‑of‑things – is attractive but fraught with execution risk. The company lacks concrete evidence of sales or regulatory approvals in these high‑growth arenas. The Q&A revealed that while they are monitoring MagNav technology, they do not have a product ready for that market, implying a gap between ambition and capability. Moreover, the capital expenditures of $2.18 million for new equipment represent a significant cash outlay; if the return on this investment does not materialize swiftly, it could pressure cash flow and limit future financing flexibility.

Equity Components Breakdown of Revenue (2025)

Peer comparison

Companies in the Semiconductors

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	NVDA	Nvidia Corp	4,021.43 Bn	33.49	18.62	8.47 Bn
2	AVGO	Broadcom Inc.	1,391.06 Bn	55.47	20.37	66.06 Bn
3	MU	Micron Technology Inc	362.63 Bn	15.01	6.24	10.14 Bn
4	AMD	Advanced Micro Devices Inc	318.39 Bn	73.43	9.19	3.22 Bn
5	INTC	Intel Corp	186.59 Bn	-457.67	3.53	46.59 Bn
6	TXN	Texas Instruments Inc	169.41 Bn	34.07	9.58	14.05 Bn
7	ADI	Analog Devices Inc	148.13 Bn	55.09	12.60	8.14 Bn
8	ARM	Arm Holdings Plc /Uk	143.86 Bn	182.68	35.90	-

Research Tools

Nve Corp /New/ (NASDAQ: NVEC)

About

Investment thesis

Bull case

Bear case

Equity Components Breakdown of Revenue (2025)

Peer comparison

Research Tools

Nve Corp /New/ (NASDAQ: NVEC)

About

Investment thesis

Bull case

Bear case

Equity Components Breakdown of Revenue (2025)

Peer comparison

Create an account

Sign In

Reset Password